Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jul 3;71(8):1132–1140. doi: 10.1002/acr.23724

Table 4.

Predictors of Highly Effective Contraception versus Moderately Effective Contraception (n=787)

Unadjusted
OR (95%CI)  p value 		  Adjusted
OR (95%CI)  p value
FDA Medication Risk Category
Class D/X 2.40 (1.57-3.65) <0.0001 2.26 (1.44-3.54) <0.0001
Class A/B/C REF REF
 
Outpatient Clinic Visits
Rheumatology Visits ˃2
Visits = 2		 1.02 (0.71-1.45) 0.94 0.80 (0.54-1.17) 0.25
PCP Visit ≥1
Visits <1		 1.54 (1.11-2.13) 0.01 1.31 (0.92-1.86) 0.13
Gynecology Visit ≥1
Visits <1		 1.56 (1.13-2.17) 0.0008 1.51 (1.07-2.14) 0.02

Table 4 includes unadjusted and adjusted odds ratios. Reference category for all models is Moderately Effective Contraception. Adjusted models include all covariates in addition to age, race, and marital status.